Gillian Gresham1, Sydney M Dy2, Vadim Zipunnikov3, Ilene S Browner4, Stephanie A Studenski5, Eleanor M Simonsick5, Luigi Ferrucci5, Jennifer A Schrack1,5,6. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2. Department of Health Policy and Management and Primary Care for Cancer Survivors Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland. 5. Intramural Research Program, National Institute on Aging, Baltimore, Maryland. 6. Center on Aging and Health, Johns Hopkins University, Baltimore, Maryland.
Abstract
BACKGROUND: Fatigue is prevalent and distressing among cancer survivors, but its subjective nature makes it difficult to identify. Fatigability, defined as task-specific fatigue, and endurance performance may be useful supplemental measures of functional status in cancer survivors. METHODS: Fatigability, endurance performance, and cancer history were assessed every 2 years in Baltimore Longitudinal Study of Aging participants between 2007 and 2015. Fatigability was defined according to the Borg rating of perceived exertion scale after a 5-minute, slow treadmill walk; and endurance performance was calculated according to the ability and time to complete a fast-paced, 400-meter walk. The association between cancer history, fatigability, and endurance performance was evaluated using longitudinal analyses adjusted for age, sex, body mass index, and comorbidities. RESULTS: Of 1665 participants, 334 (20%) reported a history of cancer. A combination of older age (>65 years) and a history of cancer was associated with 3.8 and 8.6 greater odds of high perceived fatigability and poor endurance, respectively (P < .01). Older adults with and without a history of cancer walked 42 and 23 seconds slower than younger adults without a history of cancer, respectively (P < .01). The median times to the development of high fatigability and poor endurance were shorter among those who had a history of cancer compared with those who had no history of cancer (P < .01). CONCLUSIONS: The current findings suggest that a history of cancer is associated with fatigability and poor endurance and that this effect is significantly greater in older adults. Evaluating the effects of cancer and age on fatigability may illuminate potential pathways and targets for future interventions. Cancer 2018;124:1279-87.
BACKGROUND:Fatigue is prevalent and distressing among cancer survivors, but its subjective nature makes it difficult to identify. Fatigability, defined as task-specific fatigue, and endurance performance may be useful supplemental measures of functional status in cancer survivors. METHODS: Fatigability, endurance performance, and cancer history were assessed every 2 years in Baltimore Longitudinal Study of Aging participants between 2007 and 2015. Fatigability was defined according to the Borg rating of perceived exertion scale after a 5-minute, slow treadmill walk; and endurance performance was calculated according to the ability and time to complete a fast-paced, 400-meter walk. The association between cancer history, fatigability, and endurance performance was evaluated using longitudinal analyses adjusted for age, sex, body mass index, and comorbidities. RESULTS: Of 1665 participants, 334 (20%) reported a history of cancer. A combination of older age (>65 years) and a history of cancer was associated with 3.8 and 8.6 greater odds of high perceived fatigability and poor endurance, respectively (P < .01). Older adults with and without a history of cancer walked 42 and 23 seconds slower than younger adults without a history of cancer, respectively (P < .01). The median times to the development of high fatigability and poor endurance were shorter among those who had a history of cancer compared with those who had no history of cancer (P < .01). CONCLUSIONS: The current findings suggest that a history of cancer is associated with fatigability and poor endurance and that this effect is significantly greater in older adults. Evaluating the effects of cancer and age on fatigability may illuminate potential pathways and targets for future interventions. Cancer 2018;124:1279-87.
Authors: Joanne E Mortimer; Andrea M Barsevick; Charles L Bennett; Ann M Berger; Charles Cleeland; Shannon R DeVader; Carmen Escalante; Jeffrey Gilreath; Arti Hurria; Tito R Mendoza; Hope S Rugo Journal: J Natl Compr Canc Netw Date: 2010-12 Impact factor: 11.908
Authors: Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell Journal: J Cancer Surviv Date: 2015-04-16 Impact factor: 4.442
Authors: Carolyn Miller Reilly; Deborah Watkins Bruner; Sandra A Mitchell; Lori M Minasian; Ethan Basch; Amylou C Dueck; David Cella; Bryce B Reeve Journal: Support Care Cancer Date: 2013-01-12 Impact factor: 3.603
Authors: Justin C Brown; Tania B Huedo-Medina; Linda S Pescatello; Shannon M Pescatello; Rebecca A Ferrer; Blair T Johnson Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-11-04 Impact factor: 4.254
Authors: Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia Journal: Cell Cycle Date: 2011-07-01 Impact factor: 4.534
Authors: Jennifer A Schrack; Amal A Wanigatunga; Vadim Zipunnikov; Pei-Lun Kuo; Eleanor M Simonsick; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Amal A Wanigatunga; Gillian K Gresham; Pei-Lun Kuo; Pablo Martinez-Amezcua; Vadim Zipunnikov; Sydney M Dy; Eleanor M Simonsick; Luigi Ferrucci; Jennifer A Schrack Journal: Cancer Date: 2018-10-01 Impact factor: 6.860
Authors: Kelsea R LaSorda; Theresa Gmelin; Allison L Kuipers; Robert M Boudreau; Adam J Santanasto; Kaare Christensen; Sharon W Renner; Mary K Wojczynski; Stacy L Andersen; Stephanie Cosentino; Nancy W Glynn Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Elizabeth A Salerno; Amal A Wanigatunga; Yang An; Jacek K Urbanek; Eleanor M Simonsick; Luigi Ferrucci; Susan M Resnick; Jennifer A Schrack Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Jennifer L Guida; Tim A Ahles; Daniel Belsky; Judith Campisi; Harvey Jay Cohen; James DeGregori; Rebecca Fuldner; Luigi Ferrucci; Lisa Gallicchio; Leonid Gavrilov; Natalia Gavrilova; Paige A Green; Chamelli Jhappan; Ronald Kohanski; Kevin Krull; Jeanne Mandelblatt; Kirsten K Ness; Ann O'Mara; Nathan Price; Jennifer Schrack; Stephanie Studenski; Olga Theou; Russell P Tracy; Arti Hurria Journal: J Natl Cancer Inst Date: 2019-12-01 Impact factor: 13.506
Authors: Min Kyeong Jang; Sue Kim; Chang Gi Park; Eileen G Collins; Lauretta T Quinn; Nancy W Glynn; Carol Estwing Ferrans Journal: Health Qual Life Outcomes Date: 2021-07-12 Impact factor: 3.186